Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-10-02

FDA Approved: NIFEDIPINE — Supplemental Application (Leading Pharma, LLC)

View source ↗

Summary

FDA approved a supplemental application for a nifedipine product from Leading Pharma, LLC, associated with an approved generic (ANDA074045).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nifedipine (nifedipine)

Snippet

SUPPL AP for NIFEDIPINE (NIFEDIPINE)